Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in non-small cell lung cancer patients with intestinal lung disease. A multicenter non randomized trial. - NHOK-HypoCis

ational Hospital Organization Kinki -Chuo Medical Center0 个研究点目标入组 35 人开始时间: 2016年7月15日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Exclusion criteria were as follows 1) All 1-3 were found within 30 days or possibility of acute exacerbation of intestinal lung disease. 1. worsening of respiratory distress 2. emerging ground grass attenuation or consolidation of the lung by computed tomography 3. worsening of PaO2 >= 10Torr 2) lung cancer had not been treated within 30 days 3) active double cancer 4) allergic reaction for lidocaine 5) carcinomatous pericarditis 6) uncontrolled heart failure 7) myocardial infarction within 30days 8) unstable angina pectoris 9) active infectious diseases 10) drug allery>= Grade3 11) Pregnancy, lactating woman, women of childbearing potential and patients not intend to prevent pregnancy 12) allergic pulmonary disorders or acute exacerbation of intestinal lung diseases 13) surgical treatment had previously been done for thorax in the malignant effusion 14) steroid usage (predonine >= 5mg) 15) SpO2 <90(under room air) 16) physician assessed that patients are not adequate for this study

发起方

ational Hospital Organization Kinki -Chuo Medical Center